Axon Enterprise, Inc.
490.00USD
-15.4300 (-3.05%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.96▼ | $2.02 | 5 | 9 |
| Next quarter | $2.28▲ | $2.27 | 10 | 6 |
| Current year | $7.67▼ | $7.69 | 11 | 5 |
| Next year | $10.57▲ | $10.57 | 12 | 5 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.84 | $1.88 | +0.04 (+2.0%) |
| 2026-03-31 | $1.6 | $1.61 | +0.01 (+0.8%) |
| 2025-12-31 | $1.6 | $2.15 | +0.55 (+34.5%) |
| 2025-09-30 | $1.54 | $1.17 | -0.37 (-24.1%) |
175 ratings from 25 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Argus Research | Maintained | Buy | $460 $600 | Sep 3, 2026 |
| UBS | Maintained | Neutral | $440 $600 | Aug 6, 2026 |
| Morgan Stanley | Maintained | Overweight | $600 $640 | Aug 6, 2026 |
| Piper Sandler | Maintained | Overweight | $724 $732 | Aug 6, 2026 |
| Barclays | Maintained | Overweight | $523 $688 | Aug 6, 2026 |
| Piper Sandler | Maintained | Overweight | $674 $724 | Jul 13, 2026 |
| Needham | Maintained | Buy | $600 $750 | Jul 6, 2026 |
| Citizens | Reiterated | Market Outperform | $700 | Jun 25, 2026 |
| Barclays | Maintained | Overweight | $682 $523 | May 8, 2026 |
| UBS | Maintained | Neutral | $570 $440 | May 7, 2026 |
| JP Morgan | Maintained | Overweight | $750 $755 | May 7, 2026 |
| Citizens | Maintained | Market Outperform | $825 $700 | May 7, 2026 |
| Piper Sandler | Maintained | Overweight | $690 $674 | May 7, 2026 |
| JP Morgan | Maintained | Overweight | $925 $750 | Apr 16, 2026 |
| Citizens | Reiterated | Market Outperform | $825 | Apr 13, 2026 |
| TD Cowen | Maintained | Buy | $950 $825 | Apr 8, 2026 |
| Goldman Sachs | Maintained | Buy | $720 $625 | Apr 8, 2026 |
| UBS | Maintained | Neutral | $610 $570 | Feb 25, 2026 |
| Barclays | Maintained | Overweight | $702 $682 | Feb 25, 2026 |
| Morgan Stanley | Maintained | Overweight | $713 $675 | Feb 25, 2026 |
| RBC Capital | Maintained | Outperform | $860 $735 | Feb 25, 2026 |
| Piper Sandler | Maintained | Overweight | $753 $690 | Feb 25, 2026 |
| Needham | Maintained | Buy | $870 $600 | Feb 20, 2026 |
| Morgan Stanley | Maintained | Overweight | $760 $713 | Dec 17, 2025 |
| RBC Capital | Initiated | Outperform | $860 | Nov 17, 2025 |
174 filings from 24 insiders · 22 buy / 19 sell over 6m
Officers and directors of AXON, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mak Jennifer HOfficer, Chief Accounting Officer | Tax | 155.674 | $566.56 | $88k | Aug 31, 2026 |
| Brooks CameronOfficer, CHIEF REVENUE OFFICER | Tax | 734.82 | $566.56 | $416k | Aug 31, 2026 |
| Coughlin Elizabeth ReidOfficer, Chief Human Officer | Tax | 479.268 | $566.56 | $272k | Aug 31, 2026 |
| Fields IsaiahOfficer, Chief Legal Officer | Tax | 763.159 | $566.56 | $432k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 40 | $595.17 | $24k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 91 | $592.51 | $54k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 109 | $590.21 | $64k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 280 | $588.46 | $165k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 280 | $586.43 | $164k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 565 | $585.72 | $331k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 477 | $584.54 | $279k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 120 | $582.84 | $70k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 318 | $581.76 | $185k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 793 | $580.59 | $460k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 1.7k | $579.76 | $964k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 1.4k | $578.73 | $798k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 625 | $577.74 | $361k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 1.1k | $576.80 | $620k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 1.1k | $575.79 | $638k | Aug 31, 2026 |
| Isner JoshuaOfficer, PRESIDENT | Sell | 283 | $574.67 | $163k | Aug 31, 2026 |
No analyst notes on AXON yet.
Analyst Ratings
19 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 8 | 10 | 2 | 0 | 1 | Buy1.86 |
| 1 mo ago | 8 | 10 | 2 | 0 | 1 | Buy1.86 |
| 2 mo ago | 8 | 10 | 2 | 0 | 1 | Buy1.86 |
| 3 mo ago | 8 | 10 | 2 | 0 | 0 | Buy1.70 |